Correlation Between Western Asset and Franklin Biotechnology

Can any of the company-specific risk be diversified away by investing in both Western Asset and Franklin Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Western Asset and Franklin Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Western Asset Adjustable and Franklin Biotechnology Discovery, you can compare the effects of market volatilities on Western Asset and Franklin Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Western Asset with a short position of Franklin Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Western Asset and Franklin Biotechnology.

Diversification Opportunities for Western Asset and Franklin Biotechnology

0.23

Correlation Coefficient

Western Asset  Franklin Biotechnology

Modest diversification

The 3 months correlation between Western and Franklin is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding Western Asset Adjustable and Franklin Biotechnology Discove in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Franklin Biotechnology and Western Asset is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Western Asset Adjustable are associated (or correlated) with Franklin Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Franklin Biotechnology has no effect on the direction of Western Asset i.e., Western Asset and Franklin Biotechnology go up and down completely randomly.

Pair Corralation between Western Asset and Franklin Biotechnology

Assuming the 90 days horizon Western Asset is expected to generate 1.48 times less return on investment than Franklin Biotechnology. But when comparing it to its historical volatility, Western Asset Adjustable is 14.43 times less risky than Franklin Biotechnology. It trades about 0.26 of its potential returns per unit of risk. Franklin Biotechnology Discovery is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  12,825  in Franklin Biotechnology Discovery on December 23, 2024 and sell it today you would earn a total of  195.00  from holding Franklin Biotechnology Discovery or generate 1.52% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Western Asset Adjustable  vs.  Franklin Biotechnology Discove

Western Asset Adjustable

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Western Asset Adjustable are ranked lower than 20 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong basic indicators, Western Asset is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Franklin Biotechnology

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Franklin Biotechnology Discovery are ranked lower than 2 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong basic indicators, Franklin Biotechnology is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Western Asset and Franklin Biotechnology

The main advantage of trading using opposite Western Asset and Franklin Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Western Asset position performs unexpectedly, Franklin Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Franklin Biotechnology will offset losses from the drop in Franklin Biotechnology's long position.

The idea behind Western Asset Adjustable and Franklin Biotechnology Discovery pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.